Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-15-002167
Filing Date
2015-04-24
Accepted
2015-04-24 11:48:03
Documents
5
Effectiveness Date
2015-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a_042315.htm DEFA14A 25820
2 nacard_1.jpg GRAPHIC 174634
3 nacard_2.jpg GRAPHIC 295604
4 nacard_3.jpg GRAPHIC 128971
5 nacard_4.jpg GRAPHIC 23240
  Complete submission text file 0001171843-15-002167.txt   885069
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 15790680
SIC: 3841 Surgical & Medical Instruments & Apparatus